Kilter Group’s Quest Diagnostics DGX Stock Holding History

Kilter Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.72K	Buy	27 +13	+93%	+$2.55K	﹤0.01%	635
2026 Q1	$2.74K	Buy	14 +9	+180%	+$1.75K	﹤0.01%	826
2025 Q4	$868	Hold	5	–	–	﹤0.01%	1099
2025 Q3	$953	Hold	5	–	–	﹤0.01%	897
2025 Q2	$899	Buy	+5	New	+$868	﹤0.01%	847

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Kilter Group's DGX Position: Q2 2026 in Review

Kilter Group increased its Quest Diagnostics (DGX) stake by 93% in Q2 2026, buying an estimated $2.55K and bringing the position to 27 shares worth $5.72K. The position accounts for ﹤0.01% of the portfolio, ranked #635.

Kilter Group first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Kilter Group held 27 shares of Quest Diagnostics worth $5.72K as of Q2 2026.
Kilter Group bought 13 Quest Diagnostics shares in Q2 2026, an estimated $2.55K.
Quest Diagnostics made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #635 holding.
Kilter Group first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.